GA4GH Genomics Standards (htsget, DRS, TES, WES, Beacon, Passports)
Register + standard market (ga4gh organisational membership, ga4gh implementations list). The Kin Score Market layer reads each provider in its market: who it integrates with, how deep those integrations go, and where the market publishes its own structure. Methodology.
Where this market publishes its structure
- GA4GH organisational members (ga4gh.org/community/organizational-members/) machine-readable, 646 rows, 617 with a website; 28 in-market providers linked; 10 out-of-market; 248 held by member type / host
- GA4GH implementations list (ga4gh.org/our-products/implementations/) machine-readable, 38 named implementations; 0 linked (public data commons / archives; github.com shared host)
- GA4GH products page (ga4gh.org/our-products/) machine-readable, product list only (context: standards names); carries no organisations
- github.com/ga4gh spec READMEs (task-execution-schemas, workflow-execution-service-schemas implementation lists) machine-readable, 50 rows, community-provided with an explicit no-compliance disclaimer: shape, report-only; 46 on shared hosts (github.com), 0 in-market links
- GA4GH Service Registry (registry.ga4gh.org) machine-readable, read by life-sciences (sweep-life-sciences.py); not re-read, edges reused
- GA4GH conformance / certification register not machine-readable: none published: GA4GH and its README lists disclaim compliance and endorsement (2026-10-22)
- GA4GH driver projects (ga4gh.org/our-community/driver-projects/) not machine-readable: page renders no project list in the served HTML (no list items, no external links); not bypassed
Own = declares at least one integration itself; covered = visible only because an aggregator, standards body, regulator or partner contract names it; distribution-only = listed only on cloud marketplaces it sells through, a channel reported beside, never counted as its own declared integrations; undeclared = nothing we can read, so no number; declares_compatibility = providers with a `compatible` shape vote, report only (kin, 2026-10-13): never counted as own, never in depth or position.
Taxonomy how this market maps onto apis.io
Derived 2026-10-23 from the 50 providers in this market we could resolve in the catalog. The percentage is the share of those providers carrying each one; it describes the market, not the tag or industry. Tag groups have no page of their own yet, so they are listed unlinked.
| Tags | Life Sciences 74%, Healthcare 56%, Bioinformatics 42%, Genomics 40%, Biotechnology 34% |
|---|---|
| Tag groups | Healthcare 98% |
| Industries | Biotechnology & Drug Discovery 80%, Life Sciences 74%, Healthcare 62%, Digital Health & Telehealth 30%, Pharmaceutical 22% |
| Areas | Machine Learning 12% |
share of resolved cohort carrying it; tags >=0.20 & >=3 members (max 12, junk dropped), tag_groups >=0.20 (cooccurrence, non-cross-cutting; max 8), industries >=0.20 (max 6), areas >=0.10 (max 6; areas are keyword-matched and sparse), capabilities L1 >=0.20 (max 8); derive-market-taxonomy.py
Leaders by position (provisional)
Provisional: grouped by position, depth compared within a position only. Distribution (cloud marketplaces) and iPaaS bridges are counted beside position, never inside it. Unknown-builder listings are left out of position shares and counted here.
builds-on 1 · publishes apps on other platforms' stores
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| Seqera Labs | 34.9 | 4 | 0 / 4 | 0 | 1 | 1 | ipaas-bridge 25%, builds-on-platform 50%, distribution 25% |
coverage 1 · reaches banks, carriers, systems or channels (an aggregator)
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| Epic Systems | 54.7 | 19 | 0 / 19 | 0 | 0 | 0 | contract 16%, standard 21%, coverage 63% |
regulated 8 · named in a regulator's register or partners' contracts
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| Foundation Medicine | 59.7 | 3 | 0 / 3 | 0 | 0 | 0 | contract 67%, standard 33% |
| Thermo Fisher Scientific | 59.2 | 7 | 0 / 7 | 0 | 0 | 0 | contract 71%, standard 29% |
| Eli Lilly | 58.5 | 10 | 0 / 10 | 0 | 0 | 0 | contract 50%, standard 50% |
| Flatiron Health | 57.9 | 3 | 0 / 3 | 0 | 0 | 0 | contract 67%, standard 33% |
| DNAnexus | 46.9 | 7 | 0 / 7 | 0 | 3 | 0 | contract 29%, standard 29%, distribution 43% |
| Seven Bridges | 38.8 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 50%, standard 50% |
| IQVIA | 38.6 | 6 | 0 / 6 | 0 | 4 | 0 | contract 17%, standard 17%, distribution 67% |
| Metabolon | 19.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | contract 100% |
standard 26 · listed by a voluntary standard's own directory
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals | 63.3 | 7 | 0 / 7 | 0 | 0 | 0 | contract 43%, standard 57% |
| Sanofi | 59.7 | 5 | 0 / 5 | 0 | 0 | 0 | contract 40%, standard 60% |
| Merck | 57.8 | 6 | 0 / 6 | 0 | 0 | 0 | contract 33%, standard 67% |
| Roche | 56.4 | 7 | 0 / 7 | 0 | 0 | 0 | contract 29%, standard 71% |
| Amgen | 56.0 | 6 | 0 / 6 | 0 | 0 | 0 | contract 33%, standard 67% |
| Biogen | 56.0 | 6 | 0 / 6 | 0 | 0 | 0 | contract 33%, standard 67% |
| GSK | 55.0 | 5 | 0 / 5 | 0 | 0 | 0 | contract 20%, standard 80% |
| Optum | 53.0 | 12 | 0 / 12 | 0 | 3 | 0 | contract 7%, standard 57%, builds-on-platform 14%, distribution 21% |
| Philips | 51.4 | 10 | 0 / 10 | 0 | 1 | 0 | standard 60%, builds-on-platform 20%, distribution 10%, atp-outside 10% |
| Clarivate | 50.1 | 6 | 0 / 6 | 0 | 1 | 0 | contract 17%, standard 50%, builds-on-platform 17%, distribution 17% |
| Invitae | 48.5 | 4 | 0 / 4 | 0 | 1 | 0 | contract 25%, standard 50%, distribution 25% |
| Dyno | 34.5 thin | 2 | 0 / 2 | 0 | 0 | 0 | standard 100% |
| Labcorp | 34.5 thin | 2 | 0 / 2 | 0 | 0 | 0 | standard 100% |
| Lifebit Biotech | 34.5 | 4 | 0 / 4 | 0 | 3 | 0 | standard 25%, distribution 75% |
| MyOme | 34.5 thin | 2 | 0 / 2 | 0 | 0 | 0 | standard 100% |
| ORCID | 34.5 thin | 2 | 0 / 2 | 0 | 0 | 0 | standard 100% |
| Apheris | 26.8 thin | 2 | 0 / 2 | 0 | 1 | 0 | standard 50%, distribution 50% |
| Cdisc | 26.8 thin | 2 | 0 / 2 | 0 | 1 | 0 | standard 50%, distribution 50% |
| Genialis | 26.8 thin | 2 | 0 / 2 | 0 | 1 | 0 | standard 50%, distribution 50% |
| Admera Health | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| Cancer.gov | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| Color | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| Inscripta | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| Ixlayer | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| National Center for Biotechnology Information (NCBI) | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| Syapse | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
mixed 1 · no single mode dominates
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| Verily Life Sciences | 48.4 | 3 | 0 / 3 | 0 | 1 | 0 | contract 33%, standard 33%, distribution 33% |
distribution 3 · only sells through cloud marketplaces
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| TileDB | 28.7 | 4 | 0 / 4 | 0 | 4 | 0 | distribution 100% |
| Gencove | 9.6 thin | 1 | 0 / 1 | 0 | 2 | 0 | distribution 100% |
| One Codex | 9.6 thin | 1 | 0 / 1 | 0 | 1 | 0 | distribution 100% |
undeclared 10 · declares nothing we can read: no number
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| A-Alpha Bio | undeclared | - | - | - | - | - | |
| Amazon HealthOmics | undeclared | - | - | - | - | - | |
| Element Biosciences | undeclared | - | - | - | - | - | |
| EvolutionaryScale | undeclared | - | - | - | - | - | |
| LinusBio | undeclared | - | - | - | - | - | |
| PubChem | undeclared | - | - | - | - | - | |
| Strand AI | undeclared | - | - | - | - | - | |
| Synthego | undeclared | - | - | - | - | - | |
| Washington University in St. Louis | undeclared | - | - | - | - | - | |
| Watchmaker Genomics | undeclared | - | - | - | - | - |
Generated 2026-10-24 from API Evangelist's own files; nothing on this page is a model's judgement. Provisional and unweighted; not part of the Kin Score composite or agent readiness. Read the Market layer methodology. Disagree with an edge? Every edge cites its evidence and can be corrected through the normal correction path.